Drug Approval | September 02, 2025
FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
The inspection concluded with zero Form 483 observations
Changhua site meets international regulatory standards for global medical applications
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
Subscribe To Our Newsletter & Stay Updated
